NDV HN Inhibitors

These chemicals are primarily designed to inhibit the neuraminidase function of influenza viruses, but due to the functional similarities, they could affect NDV HN as well. The degree of effectiveness would likely vary, and off-target effects could limit their practical use.NDV HN inhibitors would encompass a range of molecules designed to target the enzymatic activities associated with the HN protein of Newcastle Disease Virus. The primary action of these inhibitors would be to either prevent the virus from binding to sialic acid-containing receptors on the host cell surface or inhibit the cleavage of these receptors, which is necessary for the viral life cycle. The binding prevention would be facilitated by molecular mimicry where the inhibitor resembles the structure of sialic acid, the natural substrate for HN, thus blocking the receptor-binding sites and preventing the fusion of the virus with the host cell membrane.

The second type of inhibition targets the neuraminidase activity, which is crucial for the release of newly formed viral particles from the host cell. Inhibitors like Zanamivir and Oseltamivir are structurally similar to sialic acid and can fit into the active site of the neuraminidase, blocking its function.